{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T17:12:58Z","timestamp":1762017178947,"version":"3.33.0"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1097\/ftd.0b013e31802bb2aa","type":"journal-article","created":{"date-parts":[[2007,2,15]],"date-time":"2007-02-15T08:58:32Z","timestamp":1171529912000},"page":"27-39","source":"Crossref","is-referenced-by-count":30,"title":["Comparison of Urinary On-Site Immunoassay Screening and Gas Chromatography-Mass Spectrometry Results of 111 Patients With Suspected Poisoning Presenting at an Emergency Department"],"prefix":"10.1097","volume":"29","author":[{"given":"Marc-A von","family":"Mach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carola","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus R","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig S","family":"Weilemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans H","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank T","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210129","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1515\/CCLM.2004.250","article-title":"Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and\/or doping control.","volume":"42","author":"Maurer","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"R2-5-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0378-4347(99)00266-2","article-title":"Systematic toxicological analysis procedures for acidic drugs and\/or metabolites relevant to clinical and forensic toxicology or doping control.","volume":"733","author":"Maurer","year":"1999","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"R3-5-20210129","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0009-8981(01)00714-8","article-title":"Urine drug screening in the medical setting.","volume":"315","author":"Hammett-Stabler","year":"2002","journal-title":"Clin Chim Acta"},{"key":"R4-5-20210129","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1515\/CCLM.2004.249","article-title":"Position of immunological techniques in screening in clinical toxicology.","volume":"42","author":"George","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"R5-5-20210129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00007691-200102000-00009","article-title":"Urine drug screens in overdose patients do not contribute to immediate clinical management.","volume":"23","author":"Montague","year":"2001","journal-title":"Ther Drug Monit"},{"key":"R6-5-20210129","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1373\/49.3.357","article-title":"National academy of clinical biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department.","volume":"49","author":"Wu","year":"2003","journal-title":"Clin Chem"},{"key":"R7-5-20210129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0009-8981(02)00240-1","article-title":"Signify ER Drug Screen Test evaluation: comparison to Triage Drug of Abuse Panel plus tricyclic antidepressants.","volume":"328","author":"Phillips","year":"2003","journal-title":"Clin Chim Acta"},{"key":"R8-5-20210129","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0735-6757(85)90161-5","article-title":"Comprehensive toxicology screening in the emergency department: an aid to clinical diagnosis.","volume":"3","author":"Taylor","year":"1985","journal-title":"Am J Emerg Med"},{"key":"R9-5-20210129","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/emj.20.1.25","article-title":"Comprehensive drug screening in decision making of patients attending the emergency department for suspected drug overdose.","volume":"20","author":"Fabbri","year":"2003","journal-title":"Emerg Med J"},{"key":"R10-5-20210129","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/emj.2003.012344","article-title":"A combined HPLC-immunoenzymatic comprehensive screening for suspected drug poisoning in the emergency department.","volume":"21","author":"Fabbri","year":"2004","journal-title":"Emerg Med J"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1055\/s-2003-39251","article-title":"[Current diagnosis of poisoning.","volume":"128","author":"von Mach","year":"2003","journal-title":"] Dtsch Med Wochenschr"},{"key":"R12-5-20210129","first-page":"383","article-title":"Point-of-care testing for drugs of abuse in an urban emergency department.","volume":"32","author":"Mastrovitch","year":"2002","journal-title":"Ann Clin Lab Sci"},{"key":"R13-5-20210129","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/clinchem\/43.3.498","article-title":"Automated liquid-chromatographic analyzer used for toxicology screening in a general hospital: 12 months experience.","volume":"43","author":"Sadeg","year":"1997","journal-title":"Clin Chem"},{"key":"R14-5-20210129","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00007691-200106000-00018","article-title":"Comprehensive drug screening by integrated use of gas chromatography\/mass spectrometry and Remedi HS.","volume":"23","author":"Valli","year":"2001","journal-title":"Ther Drug Monit"},{"key":"R15-5-20210129","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00007691-199802000-00018","article-title":"Drug screening of patients who deliberately harm themselves admitted to the emergency department.","volume":"20","author":"Skelton","year":"1998","journal-title":"Ther Drug Monit"},{"key":"R16-5-20210129","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1081\/CLT-120026511","article-title":"Suspected pediatric ingestions: effectiveness of immunoassay screens vs gas chromatography\/mass spectroscopy in the detection of drugs and chemicals.","volume":"41","author":"Kyle","year":"2003","journal-title":"J Toxicol Clin Toxicol"},{"key":"R18-5-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/15563659809028940","article-title":"Poisoning severity score. Grading of acute poisoning.","volume":"36","author":"Persson","year":"1998","journal-title":"J Toxicol Clin Toxicol"},{"key":"R19-5-20210129","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jchromb.2005.07.007","article-title":"Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography-mass spectrometry.","volume":"824","author":"Ewald","year":"2005","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"R20-5-20210129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1423-0410.2003.00264.x","article-title":"Prevalence of illicit drug use in plasmapheresis donors.","volume":"84","author":"Peters","year":"2003","journal-title":"Vox Sang"},{"key":"R22-5-20210129","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/jat\/18.5.278","article-title":"Drugs-of-abuse testing in urine: statistical approach and experimental comparison of immunochemical and chromatographic techniques.","volume":"18","author":"Ferrara","year":"1994","journal-title":"J Anal Toxicol"},{"key":"R23-5-20210129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0379-0738(01)00451-0","article-title":"A comparison between on-site immunoassay drug-testing devices and laboratory results.","volume":"121","author":"Gronholm","year":"2001","journal-title":"Forensic Sci Int"},{"key":"R24-5-20210129","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0735-6757(94)90266-6","article-title":"Determination of tricyclic antidepressants for ED analysis.","volume":"12","author":"Schwartz","year":"1994","journal-title":"Am J Emerg Med"},{"key":"R25-5-20210129","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/jat\/24.7.589","article-title":"Performance evaluation of four on-site drug-testing devices for detection of drugs of abuse in urine.","volume":"24","author":"Peace","year":"2000","journal-title":"J Anal Toxicol"},{"key":"R26-5-20210129","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/clinchem\/42.9.1433","article-title":"Clinical evaluation of the Triage analytic device for drugs-of-abuse testing.","volume":"42","author":"de la Torre","year":"1996","journal-title":"Clin Chem"},{"key":"R27-5-20210129","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/jat\/17.4.241","article-title":"Evaluation of the triage system for emergency drugs-of-abuse testing in urine.","volume":"17","author":"Wu","year":"1993","journal-title":"J Anal Toxicol"},{"key":"R28-5-20210129","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/00365510152379067","article-title":"Comparison of eight commercial on-site screening devices for drugs-of- abuse testing.","volume":"61","author":"Leino","year":"2001","journal-title":"Scand J Clin Lab Invest"},{"key":"R29-5-20210129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-2003-36333","article-title":"[Deliberate self-poisoning with paracetamol (acetaminophen): an analysis from 1995 to 2002.","volume":"128","author":"von Mach","year":"2003","journal-title":"] Dtsch Med Wochenschr"},{"key":"R30-5-20210129","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5414\/CPP42277","article-title":"Epidemiological assessment of 160 cases of insulin overdose recorded in a regional poisons unit.","volume":"42","author":"von Mach","year":"2004","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R31-5-20210129","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1055\/s-2002-34512","article-title":"[Increasing significance of antidepressants in deliberate self-poisoning.","volume":"127","author":"von Mach","year":"2002","journal-title":"] Dtsch Med Wochenschr"},{"issue":"Suppl 4","key":"R32-5-20210129","doi-asserted-by":"crossref","first-page":"IV9","DOI":"10.1007\/s00392-004-1402-4","article-title":"Epidemiology of cardiac dysrhythmias in acute intoxication.","volume":"93","author":"von Mach","year":"2004","journal-title":"Z Kardiol"},{"key":"R33-5-20210129","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/jat\/22.6.493","article-title":"A multiple-site laboratory evaluation of three on-site urinalysis drug-testing devices.","volume":"22","author":"Crouch","year":"1998","journal-title":"J Anal Toxicol"},{"key":"R34-5-20210129","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jemermed.2004.11.021","article-title":"Evaluation of a rapid bedside toxicology screen in patients suspected of drug toxicity.","volume":"28","author":"Tomaszewski","year":"2005","journal-title":"J Emerg Med"},{"key":"R35-5-20210129","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/jat\/26.7.493","article-title":"A field evaluation of five on-site drug-testing devices.","volume":"26","author":"Crouch","year":"2002","journal-title":"J Anal Toxicol"},{"key":"R36-5-20210129","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/clinchem\/38.4.611","article-title":"Metabolites of chlorpromazine and brompheniramine may cause false-positive urine amphetamine results with monoclonal EMIT d.a.u. immunoassay.","volume":"38","author":"Olsen","year":"1992","journal-title":"Clin Chem"},{"key":"R37-5-20210129","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/clinchem\/41.6.955","article-title":"Bupropion metabolites produce false-positive urine amphetamine results.","volume":"41","author":"Nixon","year":"1995","journal-title":"Clin Chem"},{"key":"R38-5-20210129","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/jat\/26.1.58","article-title":"High concentration of chloroquine in urine gives positive result with Amphetamine CEDIA reagent.","volume":"26","author":"Lora-Tamayo","year":"2002","journal-title":"J Anal Toxicol"},{"key":"R39-5-20210129","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0196-0644(05)80433-0","article-title":"Desipramine and amantadine causing false-positive urine test for amphetamine.","volume":"22","author":"Merigian","year":"1993","journal-title":"Ann Emerg Med"},{"key":"R40-5-20210129","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0196-0644(05)80129-5","article-title":"Doxepin causing false-positive urine test for amphetamine.","volume":"22","author":"Merigian","year":"1993","journal-title":"Ann Emerg Med"},{"key":"R41-5-20210129","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0090-9556(24)15371-8","article-title":"On the metabolism of the amphetamine-derived antispasmodic drug mebeverine: gas chromatography-mass spectrometry studies on rat liver microsomes and on human urine.","volume":"28","author":"Kraemer","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"R42-5-20210129","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00006565-200210000-00019","article-title":"Methylphenidate produces a false-positive urine amphetamine screen.","volume":"18","author":"Manzi","year":"2002","journal-title":"Pediatr Emerg Care"},{"key":"R43-5-20210129","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/clinchem\/42.10.1725","article-title":"False-positive results for urine amphetamine and opiate immunoassays in a patient intoxicated with perazine.","volume":"42","author":"Schmolke","year":"1996","journal-title":"Clin Chem"},{"key":"R44-5-20210129","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/clinchem\/35.9.1998","article-title":"Ranitidine and high concentrations of phenylpropanolamine cross react in the EMIT monoclonal amphetamine\/methamphetamine assay.","volume":"35","author":"Grinstead","year":"1989","journal-title":"Clin Chem"},{"key":"R45-5-20210129","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/clinchem\/36.7.1391a","article-title":"Ranitidine cross-reactivity in the EMIT d.a.u. Monoclonal amphetamine\/methamphetamine assay.","volume":"36","author":"Kelly","year":"1990","journal-title":"Clin Chem"},{"key":"R46-5-20210129","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00007691-200306000-00009","article-title":"Evaluation of tricyclic antidepressant false positivity in a pediatric case of cyproheptadine (Periactin) overdose.","volume":"25","author":"Yuan","year":"2003","journal-title":"Ther Drug Monit"},{"key":"R47-5-20210129","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/clinchem\/32.4.715","article-title":"Positive diphenhydramine interference in the EMIT-st assay for tricyclic antidepressants in serum.","volume":"32","author":"Sorisky","year":"1986","journal-title":"Clin Chem"},{"key":"R48-5-20210129","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1345\/aph.1G107","article-title":"Quetiapine cross-reactivity with plasma tricyclic antidepressant immunoassays.","volume":"39","author":"Caravati","year":"2005","journal-title":"Ann Pharmacother"},{"key":"R49-5-20210129","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1081\/CLT-120019122","article-title":"Quetiapine cross-reactivity among three tricyclic antidepressant immunoassays.","volume":"41","author":"Hendrickson","year":"2003","journal-title":"J Toxicol Clin Toxicol"},{"key":"R50-5-20210129","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1176\/ajp.157.1.148-a","article-title":"Quetiapine and false-positive urine drug testing for tricyclic antidepressants.","volume":"157","author":"Sloan","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R51-5-20210129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0735-6757(99)90109-2","article-title":"Utility of comprehensive toxicologic screens in children.","volume":"17","author":"Belson","year":"1999","journal-title":"Am J Emerg Med"},{"issue":"Suppl 15","key":"R52-5-20210129","first-page":"42","article-title":"SSRI safety in overdose.","volume":"59","author":"Barbey","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R53-5-20210129","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00414-005-0528-x","article-title":"Newer antidepressants: evaluation of fatal toxicity index and interaction with alcohol based on Finnish postmortem data.","volume":"119","author":"Koski","year":"2005","journal-title":"Int J Legal Med"},{"key":"R54-5-20210129","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0196-0644(96)70116-6","article-title":"Serotonin syndrome.","volume":"28","author":"Martin","year":"1996","journal-title":"Ann Emerg Med"},{"key":"R55-5-20210129","first-page":"113","article-title":"Managing antidepression overdoses.","volume":"33","author":"Miller","year":"2004","journal-title":"Emerg Med Serv"},{"key":"R56-5-20210129","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00007691-200102000-00012","article-title":"Screening for detection of new antidepressants, neuroleptics, hypnotics, and their metabolites in urine by GC-MS developed using rat liver microsomes.","volume":"23","author":"Bickeboeller-Friedrich","year":"2001","journal-title":"Ther Drug Monit"},{"key":"R57-5-20210129","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/01.ftd.0000160719.96445.91","article-title":"Screening procedure for detection of diuretics and uricosurics and\/or their metabolites in human urine using gas chromatography-mass spectrometry after extractive methylation.","volume":"27","author":"Beyer","year":"2005","journal-title":"Ther Drug Monit"},{"key":"R58-5-20210129","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/00007691-199812000-00022","article-title":"Screening for the detection of angiotensin-converting enzyme inhibitors, their metabolites, and AT II receptor antagonists.","volume":"20","author":"Maurer","year":"1998","journal-title":"Ther Drug Monit"},{"key":"R59-5-20210129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jat\/23.2.73","article-title":"Screening procedure for detection of dihydropyridine calcium channel blocker metabolites in urine as part of a systematic toxicological analysis procedure for acidics by gas chromatography-mass spectrometry (GC-MS) after extractive methylation.","volume":"23","author":"Maurer","year":"1999","journal-title":"J Anal Toxicol"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e31802bb2aa","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T20:43:08Z","timestamp":1736800988000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-200702000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e31802bb2aa","relation":{},"ISSN":["0163-4356"],"issn-type":[{"type":"print","value":"0163-4356"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}